ClinicalTrials.Veeva

Menu
C

Coastal Eye Surgeons | Greenwich, CT

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

KSI-101
EYE201
MK-8748
EYP-1901
Avacincaptad Pegol
Providone
IRX-101
Iodine
BI 1584862

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 8 total trials
Locations recently updated

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) (TORRONTES)

Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD).Available standard (usual) treatments for NVAMD, s...

Enrolling
Choroidal Neovascularization
Age-Related Macular Degeneration
Drug: Tiespectus
Drug: Aflibercept

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants with Macular Edema Secondary to Inflammation (MESI)

Enrolling
Macular Edema Secondary to Inflammation
Other: Sham Comparator
Drug: KSI-101

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants with Macular Edema Secondary to Inflammation (MESI)

Enrolling
Macular Edema Secondary to Inflammation
Drug: KSI-101
Other: Sham Comparator

This study is open to adults aged 50 years and older with geographic atrophy that was diagnosed by imaging of the retina. The purpose of this study i...

Active, not recruiting
Geographic Atrophy
Drug: BI 1584862
Drug: Placebo-matching BI 1584862

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

Active, not recruiting
Diabetic Macular Edema (DME)
Diabetic Macular Edema
Drug: Aflibercept (2.0 mg)
Drug: EYP-1901

Trial sponsors

Kodiak Sciences logo
Astellas logo
Boehringer Ingelheim logo
E
E
I
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems